CVRx Inc

Yesterday’s bearish medium-term stance was invalidated by late-June’s F candle and Bullish Pivot Point closing above the 9/21 EMAs, signaling structural repair. CVRX now sits in an early Stage 1 consolidation below the 50 DMA with medium-term bias turned Bullish. Short-term timing is Neutral; execution should be deferred by stalking pullbacks into the 9/21 EMA support or lower consolidation boundary. A decisive close below the 9/21 EMA region would invalidate this bullish posture.

• ↑Q1 2026 revenue $14.8M (+20% YoY); U.S. heart failure sales $13.7M (+22%).
• ↑Active implanting centers grew to 257 after expanding sales force.
• ↓Q1 net loss $13.1M ($0.50/sh) underscores weak profitability.